Data from the National Venture Capital Association indicated that medtech companies in the New England area secured $505 million in venture capital financing from 46 deals last year, the highest such investment posted in the area over the past 10 years. This was in contrast to the national trend in which the medtech sector saw a 40% decline in VC investment over five years. The report also noted that 2013 numbers are on track to match last year's financing levels.

Related Summaries